FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person *   Schulenburg Gregory H. 2. Date of Event Requiring Statement (Month/Day/Year) 02/01/2012 3. Issuer Name and Ticker or Trading Symbol GREENWAY MEDICAL TECHNOLOGIES INC [GWAY] (Last) (First) (Middle) 121 GREENWAY BOULEVARD 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Exe. VP & Chief Oper. Officer 5. If Amendment, Date Original Filed(Month/Day/Year) (Street) CARROLLTON, GA 30117 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Common Stock 943 D   Common Stock 12,500 I By IRA

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Series A Convertible Preferred Stock	  (1)	  (1)	Common Stock	3,325 (1)	$ (1)	D	Â
Employee Stock Option (right to buy)	  (2)	07/01/2012	Common Stock	837	$ 4.75	D	Â
Employee Stock Option (right to buy)	  (2)	08/01/2012	Common Stock	15,000	$ 4.75	D	Â
Employee Stock Option (right to buy)	  (2)	07/01/2013	Common Stock	775	$ 4.75	D	Â
Employee Stock Option (right to buy)	  (2)	12/01/2013	Common Stock	2,400	$ 4.75	D	Â
Employee Stock Option (right to buy)	  (2)	09/15/2019	Common Stock	6,000	$ 5.19	D	Â
Employee Stock Option (right to buy)	  (3)	11/04/2019	Common Stock	12,500	$ 5.19	D	Â
Employee Stock Option (right to buy)	  (2)	06/30/2020	Common Stock	308	$ 6.92	D	Â
Employee Stock Option (right to buy)	  (4)	10/18/2020	Common Stock	6,250	$ 6.92	D	Â
Employee Stock Option (right to buy)	  (2)	02/01/2021	Common Stock	52,851	$ 7.09	D	Â
Employee Stock Option (right to buy)	  (5)	02/01/2021	Common Stock	29,657	$ 7.09	D	Â
Employee Stock Option (right to buy)	  (6)	06/28/2021	Common Stock	3,750	$ 11.58	D	Â
Employee Stock Option (right to buy)	  (7)	07/14/2021	Common Stock	6,250	$ 13.31	D	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Schulenburg Gregory H. 121 GREENWAY BOULEVARD CARROLLTON, GA 30117	Â	Â	  Exe. VP & Chief Oper. Officer	Â

Signatures

/s/ William G. Esslinger, Jr., attorney-in-fact		02/01/2012
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Each share of Series A Convertible Preferred Stock will automatically convert into 1.263 shares of common stock in connection with the completion of the Company's initial public offering and has no expiration date.
(2)	All options to purchase shares of common stock are currently exercisable.
(3)	The option vests over four years, with 25% vesting on November 4, 2010 and the remainder vesting over three years thereafter in monthly installments.
(4)	The option vests over four years, with 25% vesting on August 4, 2011 and the remainder vesting over three years thereafter in monthly installments.
(5)	The option vests over four years, with 25% vesting on February 1, 2012 and the remainder vesting over three years thereafter in monthly installments.
(6)	The option vests over four years, with 25% vesting on June 28, 2012 and the remainder vesting over three years thereafter in monthly installments.
(7)	The option vests over four years, with 25% vesting on July 14, 2012 and the remainder vesting over three years thereafter in monthly installments.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.